Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome

Magnus Mansouri Taleghani, Yoshihiro Fujimura, MD, PhD, James N. George, MD, Ingrid Hrachovinova, PhD, Paul Knoebl, MD, Bernhard Lämmle, MD, Petter Quist-Paulsen, MD, PhD, Reinhard Schneppenheim, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2012) 120 (21): 4654.

https://doi.org/10.1182/blood.V120.21.4654.4654

Published: 2012

Journal Articles

Severe Depression Following Recovery From Thrombotic Thrombocytopenic Purpura (TTP)

Cassandra C. Deford, MA, Lauren H. Schwartz, MD, Jedidiah J. Perdue, MD, Jessica A. Reese, MS, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Lauren M. Stewart, MPH, Zayd L. Al-Nouri, MD, MPH, Deirdra R. Terrell, PhD, James N. George, MD, Sara K. Vesely, PhD, MPH

Blood (2012) 120 (21): 366.

https://doi.org/10.1182/blood.V120.21.366.366

Published: 2012

Journal Articles

Mortality and Morbidities During Long-Term Follow-up After Recovery From Thrombotic Thrombocytopenic Purpura (TTP)

Jessica A. Reese, MS, Zayd L. Al-Nouri, MD, MPH, Cassandra C. Deford, MA, Lauren M. Stewart, MPH, Deirdra R. Terrell, PhD, Sara K. Vesely, PhD, MPH, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, James N. George, MD

Blood (2012) 120 (21): 362.

https://doi.org/10.1182/blood.V120.21.362.362

Published: 2012

Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

Monica Schaller, PhD, Irmela Sulzer, Magnus Mansouri, MD student, Bernhard Lämmle, MD, Johanna A. Kremer Hovinga Strebel, MD

Blood (2011) 118 (21): 3299.

https://doi.org/10.1182/blood.V118.21.3299.3299

Published: 2011

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Spero R Cataland, MD, Flora Peyvandi, MD, PhD, Pier M. Mannucci, MD, Bernhard Lämmle, Johanna A Kremer Hovinga, MD, Samuel J Machin, Marie Scully, Gail Rock, PhD, MD, FRCP, James Gilbert, MD, Paul Knoebl, Shangbin Yang, PhD, Haifeng Wu, M.D., Bernd Jilma, MD

Blood (2010) 116 (21): 726.

https://doi.org/10.1182/blood.V116.21.726.726

Published: 2010

Journal Articles

Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab.

Monica M. Schaller Tschan, PhD, Karin Sprecher, Master, Irmela Sulzer, technician, Monique Vogel, PhD, Beda Stadler, Prof, Karim Kentouche, MD, Bernhard Lämmle, Prof, Johanna A. Kremer Hovinga Strebel, MD

Blood (2010) 116 (21): 1431.

https://doi.org/10.1182/blood.V116.21.1431.1431

Published: 2010

Journal Articles

Circulating Nucleosomes Reflect Disease Activity in Patients with Thrombotic Microangiopathies.

Tobias A. Fuchs, PhD, Johanna A. Kremer Hovinga, MD, Daphne Schatzberg, BS, Marc Monestier, MD, PhD, Denisa D. Wagner, PhD, Bernhard Lämmle, MD

Blood (2010) 116 (21): 1437.

https://doi.org/10.1182/blood.V116.21.1437.1437

Published: 2010

Journal Articles

Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)?

Deirdra R. Terrell, PhD, Zayd Al-Nouri, Judith A. James, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD, Bernhard Lämmle, MD, Sara K. Vesely, PhD, MPH, James N. George, MD

Blood (2010) 116 (21): 2519.

https://doi.org/10.1182/blood.V116.21.2519.2519

Published: 2010

Journal Articles

Clinical Outcomes in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (TTP) Who Received Platelet Transfusions (PT).

Karen K. Swisher, MD, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2007) 110 (11): 1302.

https://doi.org/10.1182/blood.V110.11.1302.1302

Published: 2007

Journal Articles

Neurocognitive Impairment Following Recovery from ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

Qurana F. Lewis, MPH, James G. Scott, PhD, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2007) 110 (11): 1311.

https://doi.org/10.1182/blood.V110.11.1311.1311

Published: 2007

Journal Articles

Sporadic Bloody Diarrhea-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults in Oklahoma: Comparison to Adults with Severe Adamts13 Deficiency and to Children with Typical HUS.

Loan Nguyen, Charity A. Karpac, MD, MPH, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2007) 110 (11): 1317.

https://doi.org/10.1182/blood.V110.11.1317.1317

Published: 2007

Journal Articles

The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

Karen K. Swisher, MD, Qurana F. Lewis, MPH, Judith A. James, MD, PhD, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2007) 110 (11): 2090.

https://doi.org/10.1182/blood.V110.11.2090.2090

Published: 2007

Journal Articles

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Manfred Rieger, Pier Mannuccio Mannucci, Johanna A. Kremer Hovinga, Andrea Herzog, Gabi Gerstenbauer, Christian Konetschny, Klaus Zimmermann, Inge Scharrer, Flora Peyvandi, Miriam Galbusera, Giuseppe Remuzzi, Martina Böhm, Barbara Plaimauer, Bernhard Lämmle, Friedrich Scheiflinger

Blood (2005) 106 (4): 1262–1267.

https://doi.org/10.1182/blood-2004-11-4490

Published: 2005

Journal Articles

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Gerhard Antoine, Martin Hermann, Manfred Rieger, Friedrich Scheiflinger, Bernhard Lämmle

Blood (2005) 105 (2): 542–544.

https://doi.org/10.1182/blood-2004-06-2096

Published: 2005

Journal Articles

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich Dorner, Bernhard Lämmle, Pier Mannuccio Mannucci, Friedrich Scheiflinger

Blood (2004) 103 (12): 4514–4519.

https://doi.org/10.1182/blood-2003-12-4165

Published: 2004

Journal Articles

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Radovan Radonic, Vladimir Gasparovic, Dragutin Ivanovic, Marijan Merkler, Urs Wirthmueller, Clemens Dahinden, Miha Furlan, Bernhard Lämmle

Blood (2004) 103 (11): 4195–4197.

https://doi.org/10.1182/blood-2003-11-3888

Published: 2004

Journal Articles

Discrepant activity levels of von Willebrand factor–cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura

Jan-Dirk Studt, Johanna A. Kremer Hovinga, Miha Furlan, Bernhard Lämmle

Blood (2003) 102 (3): 1148.

https://doi.org/10.1182/blood-2003-05-1466

Published: 2003

Journal Articles

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Sara K. Vesely, James N. George, Bernhard Lämmle, Jan-Dirk Studt, Lorenzo Alberio, Mayez A. El-Harake, Gary E. Raskob

Blood (2003) 102 (1): 60–68.

https://doi.org/10.1182/blood-2003-01-0193

Published: 2003

Journal Articles

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Barbara Plaimauer, Klaus Zimmermann, Dirk Völkel, Gerhard Antoine, Randolf Kerschbaumer, Pegah Jenab, Miha Furlan, Helen Gerritsen, Bernhard Lämmle, Hans Peter Schwarz, Friedrich Scheiflinger

Blood (2002) 100 (10): 3626–3632.

https://doi.org/10.1182/blood-2002-05-1397

Published: 2002

Journal Articles

Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

Valentina Bianchi, Rodolfo Robles, Lorenzo Alberio, Miha Furlan, Bernhard Lämmle

Blood (2002) 100 (2): 710–713.

https://doi.org/10.1182/blood-2002-02-0344

Published: 2002

NARROW

International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome

Severe Depression Following Recovery From Thrombotic Thrombocytopenic Purpura (TTP)

Mortality and Morbidities During Long-Term Follow-up After Recovery From Thrombotic Thrombocytopenic Purpura (TTP)

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy in Acquired TTP Is the Expression of a General Dysregulation of the Immune Response,

A Randomized, Double-Blind, Placebo-Controlled, Clinical Outcome Study of ARC1779 In Patients with Thrombotic Thrombocytopenic Purpura (TTP)

Restricted Immunglobulin Gene Usage of Spleen-Derived Specific Anti-ADAMTS13 B-Cells In Relapsing TTP Treated with or without Rituximab.

Circulating Nucleosomes Reflect Disease Activity in Patients with Thrombotic Microangiopathies.

Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)?

Clinical Outcomes in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura (TTP) Who Received Platelet Transfusions (PT).

Neurocognitive Impairment Following Recovery from ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

Sporadic Bloody Diarrhea-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults in Oklahoma: Comparison to Adults with Severe Adamts13 Deficiency and to Children with Typical HUS.

The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

Discrepant activity levels of von Willebrand factor–cleaving protease (ADAMTS-13) in congenital thrombotic thrombocytopenic purpura

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)

Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only